NCT04570098Completed
Prevalence and Prognostic Relevance of Tricuspid Regurgitation in Different Heart Failure Entities
Source: ClinicalTrials.gov · Last updated 12 Feb 2025
Brief summary (registry, in English)
The present study includes patients with tricuspid regurgitation and heart failure diagnosed with echocardiography. The aim is to evaluate the physical performance of patients with tricuspid regurgitation and heart failure, to observe the course of the diseases and to allow a better understanding of new therapy options.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1016 (actual)
- First submitted
- 20 Sept 2020
- Start date
- 26 Jul 2020
- Primary completion date
- 30 Sept 2024
- Lead sponsor
- Charite University, Berlin, Germany
- Diseases
- Heart failure
- NCT number
- NCT04570098
What you commit to
- Study type: Observational
- Participants enrolled: 1016
- From 26 Jul 2020 to the primary completion date, 30 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Patients in care or unable to consent
Who the study is looking for
- Patients with transthoracic echocardiography (TTE) and heart failure
- Reported heart failure symptoms within the last two years
- \>18 years
- Written, documented consent
Age in the registry: 18 years to 120 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Charité Universitätsmedizin Berlin Coordinator of this site? Confirm its status | Berlin | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.